Results
|
|
1981.
|
|
|
|
1982.
|
Chfr is required for tumor suppression and Aurora A regulation. [electronic resource] by
- Yu, Xiaochun
- Minter-Dykhouse, Katherine
- Malureanu, Liviu
- Zhao, Wei-Meng
- Zhang, Dongwei
- Merkle, Carolin J
- Ward, Irene M
- Saya, Hideyuki
- Fang, Guowei
- van Deursen, Jan
- Chen, Junjie
Producer: 20050421
In:
Nature genetics vol. 37
Availability: No items available.
|
|
|
1983.
|
|
|
|
1984.
|
SNS-314, a pan-Aurora kinase inhibitor, shows potent anti-tumor activity and dosing flexibility in vivo. [electronic resource] by
- Arbitrario, Jennifer P
- Belmont, Brian J
- Evanchik, Marc J
- Flanagan, W Michael
- Fucini, Raymond V
- Hansen, Stig K
- Harris, Shannon O
- Hashash, Ahmad
- Hoch, Ute
- Hogan, Jennifer N
- Howlett, Anthony R
- Jacobs, Jeffrey W
- Lam, Joni W
- Ritchie, Sean C
- Romanowski, Michael J
- Silverman, Jeffrey A
- Stockett, David E
- Teague, Juli N
- Zimmerman, Kristin M
- Taverna, Pietro
Producer: 20100205
In:
Cancer chemotherapy and pharmacology vol. 65
Availability: No items available.
|
|
|
1985.
|
Phase I, open-label, multicentre, dose-escalation, pharmacokinetic and pharmacodynamic trial of the oral aurora kinase inhibitor PF-03814735 in advanced solid tumours. [electronic resource] by
- Schöffski, Patrick
- Jones, Suzanne F
- Dumez, Herlinde
- Infante, Jeffrey R
- Van Mieghem, Elke
- Fowst, Camilla
- Gerletti, Paola
- Xu, Huiping
- Jakubczak, John L
- English, Patricia A
- Pierce, Kristen J
- Burris, Howard A
Producer: 20111121
In:
European journal of cancer (Oxford, England : 1990) vol. 47
Availability: No items available.
|
|
|
1986.
|
|
|
|
1987.
|
Targeting aurora kinases limits tumour growth through DNA damage-mediated senescence and blockade of NF-κB impairs this drug-induced senescence. [electronic resource] by
- Liu, Yan
- Hawkins, Oriana E
- Su, Yingjun
- Vilgelm, Anna E
- Sobolik, Tammy
- Thu, Yee-Mon
- Kantrow, Sara
- Splittgerber, Ryan C
- Short, Sarah
- Amiri, Katayoun I
- Ecsedy, Jeffery A
- Sosman, Jeffery A
- Kelley, Mark C
- Richmond, Ann
Producer: 20130606
In:
EMBO molecular medicine vol. 5
Availability: No items available.
|
|
|
1988.
|
|
|
|
1989.
|
|
|
|
1990.
|
|
|
|
1991.
|
The human cumulus--oocyte complex gene-expression profile. [electronic resource] by
- Assou, Said
- Anahory, Tal
- Pantesco, Véronique
- Le Carrour, Tanguy
- Pellestor, Franck
- Klein, Bernard
- Reyftmann, Lionel
- Dechaud, Hervé
- De Vos, John
- Hamamah, Samir
Producer: 20060926
In:
Human reproduction (Oxford, England) vol. 21
Availability: No items available.
|
|
|
1992.
|
|
|
|
1993.
|
|
|
|
1994.
|
Discovery, synthesis, and in vivo activity of a new class of pyrazoloquinazolines as selective inhibitors of aurora B kinase. [electronic resource] by
- Mortlock, Andrew A
- Foote, Kevin M
- Heron, Nicola M
- Jung, Frédéric H
- Pasquet, Georges
- Lohmann, Jean-Jacques M
- Warin, Nicolas
- Renaud, Fabrice
- De Savi, Chris
- Roberts, Nicola J
- Johnson, Trevor
- Dousson, Cyril B
- Hill, George B
- Perkins, David
- Hatter, Glenn
- Wilkinson, Robert W
- Wedge, Stephen R
- Heaton, Simon P
- Odedra, Rajesh
- Keen, Nicholas J
- Crafter, Claire
- Brown, Elaine
- Thompson, Katherine
- Brightwell, Stephen
- Khatri, Liz
- Brady, Madeleine C
- Kearney, Sarah
- McKillop, David
- Rhead, Steve
- Parry, Tony
- Green, Stephen
Producer: 20070626
In:
Journal of medicinal chemistry vol. 50
Availability: No items available.
|
|
|
1995.
|
AZD1152, a novel and selective aurora B kinase inhibitor, induces growth arrest, apoptosis, and sensitization for tubulin depolymerizing agent or topoisomerase II inhibitor in human acute leukemia cells in vitro and in vivo. [electronic resource] by
- Yang, Jing
- Ikezoe, Takayuki
- Nishioka, Chie
- Tasaka, Taizo
- Taniguchi, Ayuko
- Kuwayama, Yoshio
- Komatsu, Naoki
- Bandobashi, Kentaro
- Togitani, Kazuto
- Koeffler, H Phillip
- Taguchi, Hirokuni
- Yokoyama, Akihito
Producer: 20071030
In:
Blood vol. 110
Availability: No items available.
|
|
|
1996.
|
|
|
|
1997.
|
Aurora B is regulated by the mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/ERK) signaling pathway and is a valuable potential target in melanoma cells. [electronic resource] by
- Bonet, Caroline
- Giuliano, Sandy
- Ohanna, Mickaël
- Bille, Karine
- Allegra, Maryline
- Lacour, Jean-Philippe
- Bahadoran, Philippe
- Rocchi, Stéphane
- Ballotti, Robert
- Bertolotto, Corine
Producer: 20121119
In:
The Journal of biological chemistry vol. 287
Availability: No items available.
|
|
|
1998.
|
Efficiency of G2/M-related tumor-associated antigen-targeting cancer immunotherapy depends on antigen expression in the cancer stem-like population. [electronic resource] by
- Mori, Takashi
- Nishizawa, Satoshi
- Hirohashi, Yoshihiko
- Torigoe, Toshihiko
- Tamura, Yasuaki
- Takahashi, Akari
- Kochin, Vitaly
- Fujii, Reona
- Kondo, Toru
- Greene, Mark I
- Hara, Isao
- Sato, Noriyuki
Producer: 20120504
In:
Experimental and molecular pathology vol. 92
Availability: No items available.
|
|
|
1999.
|
|
|
|
2000.
|
Aurora kinase A-specific T-cell receptor gene transfer redirects T lymphocytes to display effective antileukemia reactivity. [electronic resource] by
- Nagai, Kozo
- Ochi, Toshiki
- Fujiwara, Hiroshi
- An, Jun
- Shirakata, Toshiaki
- Mineno, Junichi
- Kuzushima, Kiyotaka
- Shiku, Hiroshi
- Melenhorst, J Joseph
- Gostick, Emma
- Price, David A
- Ishii, Eiichi
- Yasukawa, Masaki
Producer: 20120306
In:
Blood vol. 119
Availability: No items available.
|